임상적으로 검증된 인 실리코(in silico) 모델링 및 시뮬레이션을 통한 면역원성 예측 및 용량 최적화
Biologic drug development is a rapidly evolving sector in the biopharmaceutical industry. Immunogenicity is an inherent challenge with this complex class of drugs. A quantitative systems pharmacology approach can be used to predict and better manage immunogenicity, and as a tool to guide clinical and regulatory decision-making in biologics drug development.